Title
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
Document Type
Article
Publication Date
12-19-2022
Publication Title
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abstract
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See Appendix 1 (online only) for disclaimers and other important information. Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline.
Volume
Online ahead of print.
First Page
2202121
Last Page
2202121
Recommended Citation
Owen DH, Singh N, Ismaila N, Blanchard E, Celano P, Florez N, et al. [Jaiyesimi IA] Therapy for stage iv non-small-cell lung cancer without driver alterations: ASCO Living Guideline, Version 2022.2. J Clin Oncol. 2022 Dec 19:JCO2202121. doi: 10.1200/JCO.22.02121. Epub ahead of print. PMID: 36534935.
DOI
10.1200/JCO.22.02121
ISSN
1527-7755
PubMed ID
36534935